Artificial Saliva Market: Current Analysis and Forecast (2022-2028)
Emphasis on Product Type (Oral Spray, Oral Solution, Oral Liquid, Gel, and Powder); Age Group (Adult and pediatric); Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Others); and Region/Country
The global artificial saliva market was valued at USD 800 Mn in 2021 and is expected to grow at a significant rate of around 13% during the forecast period (2022-2028). Artificial saliva is a substitute for natural saliva that moisturizes and smooths the mouth while also providing a barrier to reduce the risk of physical problems brought on by persistent dry mouth. It can relieve symptoms including dry mouth, stickiness, and poor breath. Many clinical situations, such as the presence of cellular components, inflammatory activators, or high glucose conditions, are not accurately modeled by artificial saliva solutions used to evaluate the electrochemical behavior of materials in the oral cavity.
The rising prevalence of dry mouth syndrome, which causes decreased salivary flow and mucosal dryness, propels the artificial saliva industry forward. As the risk of dry mouth syndrome and dysphagia rises due to radiation therapy and chemotherapy, the product’s demand is also increasing due to the growing geriatric population with a large number of cancer cases worldwide. Also rising awareness about the fewer complications associated with oral gels and liquids and rising expenditure on oral care products propel the market growth during the forecast period. For instance, approximately 89,500 cancer cases were diagnosed and about 9,270 cancer deaths in adolescents and young adults (AYAs) ages 15 to 39 years in the U.S. in 2020.
GSK plc.; Cipla Inc.; Mission Pharmacal Company; Fresenius Kabi AG; Parnell Pharmaceuticals, Inc.; CCMed Ltd.; ENTOD INTERNATIONAL; Midatech Pharma PLC; Forward Science; Bausch Health Companies Inc. are some of the key players in the market. Several M&As along with partnerships have been undertaken by these players to facilitate customers with hi-tech and innovative products/technologies.
Insights Presented in the Report
“Amongst product type, oral spray category to witness robust CAGR during the forecast period”
Based on product type, the market is segmented into oral spray, oral solution, oral liquid, gel, and powder. The oral spray category is to witness robust CAGR during the forecast period. This is mainly due to their ease of use, efficiency & low cost, and these sprays are commonly used to treat dry mouth conditions. Also, increasing product development by key players drives the growth of the segment. For instance, Mouth Kote-MD, a mouth spray based on MycoDelens, a proprietary substance created and licensed by New Mexico Tech University, was presented by Parnell Pharmaceuticals, Inc. in 2021.
“Amongst age group, the adult category dominated the growth of the artificial saliva market in 2021”
On the basis of age group, the market is bifurcated into adult and pediatric. Among these, the adult category dominated the growth of the artificial saliva market in 2021. This is mainly due to the artificial saliva being used more by adult patients and this is unlikely to change anytime soon as the dry mouth condition is typically more common in adult patients than pediatric ones.
The other factor for the growth of this segment is the growing dysphagia condition due to mouth cancer or oesophageal cancer. For instance, according to the World Cancer Research Fund (WCRF International), around 604,100 new cases of oesophageal cancer were diagnosed in 2020.
“North America to hold a significant share in the market”
For a better understanding of the market adoption of the artificial saliva industry, the market is analyzed based on its worldwide presence in the countries such as North America (U.S., Canada, Rest of North America), Europe (Germany, U.K., France, Spain, Italy, Rest of Europe), Asia-Pacific (China, Japan, India, Rest of Asia-Pacific), Rest of World. North America is anticipated to grow at a substantial CAGR during the forecast period. This is mainly due to the availability of major market key players, rising awareness about oral diseases, growing product utilization to treat xerostomia, rising disposable incomes, increasing prevalence of cancer and Alzheimer’s disease, growing technological advancements, and presence of a large patient population in the region, which is expected to aid the market growth. For instance, according to the National Center for Chronic Disease Prevention (CDC), in 2020, as many as 5.8 million Americans were living with Alzheimer’s disease.
Artificial Saliva Market Report Coverage
Reasons to buy this report:
- The study includes market sizing and forecasting analysis validated by authenticated key industry experts.
- The report presents a quick review of overall industry performance at one glance.
- The report covers an in-depth analysis of prominent industry peers with a primary focus on key business financials, product portfolio, expansion strategies, and recent developments.
- Detailed examination of drivers, restraints, key trends, and opportunities prevailing in the industry.
- The study comprehensively covers the market across different segments.
- Deep dive regional level analysis of the industry.
Customization Options:
The global artificial saliva market can further be customized as per the requirement or any other market segment. Besides this, UMI understands that you may have your own business needs, hence feel free to connect with us to get a report that completely suits your requirements.
Table of Contents
Research Methodology for the Artificial Saliva Market Analysis (2022-2028)
Analyzing the historical market, estimating the current market, and forecasting the future market of the global Artificial Saliva Market were the three major steps undertaken to create and analyze the adoption of artificial saliva markets in major regions globally. Exhaustive secondary research was conducted to collect the historical market numbers and estimate the current market size. Secondly, to validate these insights, numerous findings and assumptions were taken into consideration. Moreover, exhaustive primary interviews were also conducted, with industry experts across the value chain of the global artificial saliva market. Post assumption and validation of market numbers through primary interviews, we employed a top-down/bottom-up approach to forecasting the complete market size. Thereafter, market breakdown and data triangulation methods were adopted to estimate and analyze the market size of segments and sub-segments of the industry pertains to. Detailed methodology is explained below:
Analysis of Historical Market Size
Step 1: In-Depth Study of Secondary Sources:
Detail secondary study was conducted to obtain the historical market size of the artificial saliva market through company internal sources such as annual reports & financial statements, performance presentations, press releases, etc., and external sources including journals, news & articles, government publications, competitor publications, sector reports, third-party database, and other credible publications.
Step 2: Market Segmentation:
After obtaining the historical market size of the artificial saliva market, we conducted a detailed secondary analysis to gather historical market insights and share for different segments & sub-segments for major regions. Major segments are included in the report as product type, age group, and distribution channel. Further country-level analyses were conducted to evaluate the overall adoption of testing models in that region.
Step 3: Factor Analysis:
After acquiring the historical market size of different segments and sub-segments, we conducted a detailed factor analysis to estimate the current market size of the Artificial Saliva Market. Further, we conducted factor analysis using dependent and independent variables such as various product type, age group, and distribution channels of artificial saliva markets. A thorough analysis was conducted for demand and supply-side scenarios considering top partnerships, mergers and acquisitions, business expansion, and product launches in the artificial saliva market sector across the globe.
Current Market Size Estimate & Forecast
Current Market Sizing: Based on actionable insights from the above 3 steps, we arrived at the current market size, key players in the global artificial saliva market, and market shares of the segments. All the required percentage shares split, and market breakdowns were determined using the above-mentioned secondary approach and were verified through primary interviews.
Estimation & Forecasting: For market estimation and forecast, weights were assigned to different factors including drivers & trends, restraints, and opportunities available for the stakeholders. After analyzing these factors, relevant forecasting techniques i.e., the top-down/bottom-up approach were applied to arrive at the market forecast for 2028 for different segments and sub-segments across the major markets globally. The research methodology adopted to estimate the market size encompasses:
- The industry’s market size, in terms of revenue (USD) and the adoption rate of the artificial saliva market across the major markets domestically
- All percentage shares, splits, and breakdowns of market segments and sub-segments
- Key players in the global artificial saliva market in terms of products offered. Also, the growth strategies adopted by these players to compete in the fast-growing market
Market Size and Share Validation
Primary Research: In-depth interviews were conducted with the Key Opinion Leaders (KOLs) including Top Level Executives (CXO/VPs, Sales Head, Marketing Head, Operational Head, Regional Head, Country Head, etc.) across major regions. Primary research findings were then summarized, and statistical analysis was performed to prove the stated hypothesis. Inputs from primary research were consolidated with secondary findings, hence turning information into actionable insights.
Split of Primary Participants in Different Regions
Market Engineering
The data triangulation technique was employed to complete the overall market estimation and to arrive at precise statistical numbers for each segment and sub-segment of the global artificial saliva market. Data was split into several segments & sub-segments post studying various parameters and trends in the areas of product type, age group, and distribution channel in the global artificial saliva market.
The main objective of the Global Artificial Saliva Market Study
The current & future market trends of the global Artificial Saliva Market were pinpointed in the study. Investors can gain strategic insights to base their discretion for investments on the qualitative and quantitative analysis performed in the study. Current and future market trends determined the overall attractiveness of the market at a regional level, providing a platform for the industrial participant to exploit the untapped market to benefit from a first-mover advantage. Other quantitative goals of the studies include:
- Analyze the current and forecast market size of the artificial saliva market in terms of value (USD). Also, analyze the current and forecast market size of different segments and sub-segments
- Segments in the study include areas of product type, age group, and distribution channel.
- Define and analysis of the regulatory framework for the artificial saliva
- Analyze the value chain involved with the presence of various intermediaries, along with analyzing customer and competitor behaviors of the industry.
- Analyze the current and forecast market size of the artificial saliva market for the major region.
- Major countries of regions studied in the report include Asia Pacific, Europe, North America, and the Rest of the World.
- Company profiles of the Artificial Saliva Market and the growth strategies adopted by the market players to sustain in the fast-growing market
- Deep dive regional level analysis of the industry
Related Reports
Customers who bought this item also bought
Antibiotic Resistance Market: Current Analysis and Forecast (2024-2032)
Emphasis on Disease Type (Urinary Tract Infections, Intra-Abdominal Infections, Blood Stream Infections, Clostridium Difficile Infections, And Others); Pathogen Type (Acinetobacter baumannii, Pseudomonas aeruginosa, Staphylococcus aureus, Streptococcus pneumoniae, and Others); Drug Class (Oxazolidinones, Lipoglycopeptides, Tetracyclines, and Others); and Region/Country
October 8, 2024
